Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» CAR-T
CAR-T
ASCO cancer research data drop: What to watch
CNBC
Wed, 05/13/15 - 12:18 pm
ASCO
oncology
cancer
Merck
Bristol-Myers Squibb
AstraZeneca
Juno Therapeutics
CAR-T
Ibrance
Pfizer
elotuzumab
Opdivo
Keytruda
Bellicum buys into CAR-T manufacturing amid a hot immuno-oncology race
Fierce Biotech
Fri, 05/8/15 - 11:09 am
Bellicum
CAR-T
immuno-oncology
What biopharma needs to know about CAR-T cancer therapies
BioPharma Dive
Sun, 04/26/15 - 09:21 am
CAR-T
Novartis
CTL019
Novartis solid tumor 'CAR T cell' still holds promise - researcher
Yahoo/Reuters
Tue, 04/21/15 - 09:21 am
Novartis
solid tumors
CAR-T
Novartis' new CAR-T hopeful looks safe in an early solid tumor study
Fierce Biotech
Mon, 04/20/15 - 11:53 am
Novartis
CAR-T
immuno-oncology
It's A Big Weekend For Biotech
Yahoo/Benzinga
Sat, 04/18/15 - 11:55 am
biotech
Biogen
BIIB037
RG7800
PTC Therapeutics
Alnylam
CAR-T
Merck
Bristol-Myers Squibb
Novartis
Juno Therapeutics
Bellicum
Juno and Novartis settle CAR-T patent fight with little fanfare
Fierce Biotech
Mon, 04/6/15 - 10:07 am
Juno Therapeutics
Novartis
patents
CAR-T
Intrexon and Merck Serono Announce Agreement for the Development and Commercialization of CAR-T Therapy
Yahoo
Mon, 03/30/15 - 11:11 am
Intrexon
Merck Serono
CAR-T
chimeric antigen receptor T-cell immunotherapies
Cellectis upscales IPO toward $200M as CAR-T fever continues
Fierce Biotech
Wed, 03/25/15 - 09:45 am
Cellectis
IPOs
CAR-T
This Billionaire CEO Just Made Another Biotech Acquisition -- and Hardly Anyone Noticed
Motley Fool
Sun, 03/1/15 - 11:32 am
Intrexon
CAR-T
Zogenix
ActoGeniX
Safety concerns cloud early promise of powerful new cancer drugs
Yahoo/Reuters
Mon, 01/26/15 - 08:12 am
cancer
CAR-T
Amgen
Celgene
Bluebird Bio
Novartis
Kite Pharma
Pfizer
Cellectis
Juno Therapeutics
The CAR-T brain war: Scientific trailblazer inspires a $45M biotech startup
Fierce Biotech
Thu, 01/22/15 - 09:49 am
CAR-T
biotech
Autolus
cancer
R&D
8 Biotech Stock Controversies Emerging From 'JPM15' Conference
TheStreet.com
Tue, 01/20/15 - 11:33 am
JPMHC 2015
drug pricing
CAR-T
biotech
Gilead Sciences
immuno-oncology
Duchenne Muscular Dystrophy
Kite Pharma/Amgen: A Strong Combination
Seeking Alpha
Thu, 01/15/15 - 05:50 pm
Kite Pharma
Amgen
Juno Therapeutics
Bellicum
Ziopharm
CAR-T
After CAR-T: Getting Ahead of the Next Hot Trend in Cancer Stocks
TheStreet.com
Tue, 01/6/15 - 08:56 am
CAR-T
cancer
Juno Therapeutics
Kite Pharma
Celgene
Bluebird Bio
Cellectis Is Late To The CAR-T Cell Race, But Could Finish First
Seeking Alpha
Fri, 01/2/15 - 07:33 pm
Cellectis
CAR-T
Novartis
GSK
Bellicum
Celgene
Bluebird Bio
Bellicum pulls off a $140M IPO as CAR-T has its day on Wall Street
Fierce Biotech
Thu, 12/18/14 - 10:26 am
Bellicum
IPOs
CAR-T
Bellicum battles for CAR-T spotlight with a $121M IPO pitch
Fierce Biotech
Thu, 12/11/14 - 07:31 pm
CAR-T
Bellicum
IPOs
The 7 Most Important Drug-Stock Lessons From This Weekend's Blood Cancer Meeting
TheStreet.com
Mon, 12/8/14 - 10:30 am
Agios Pharmaceuticals
Novartis
CAR-T
Celgene
Amgen
Merck
Bristol-Myers Squibb
Seattle Genetics
Sunesis
JNJ, Transposagen To Co-Develop CAR-T Therapy
Bidness Etc.
Tue, 11/25/14 - 11:04 am
JNJ
Transposagen
CAR-T
cancer immunotherapy
Pages
« first
‹ previous
…
19
20
21
22
23
24
25
26
27
next ›
last »